G2 (Tirzepatide) is a dual GIP/GLP-1 receptor agonist referenced in metabolic, appetite-regulation, and insulin-sensitivity research. Features a novel twincretin mechanism engaging both receptor classes.
Specifications: Lyophilized. Amber glass, crimp-sealed. Per vial as selected.